Determination of Camlipixant (BLU-5937) P2X3 antagonist activity in a sensory neuronal model and bronchial epithelial cells - Vienna 2024

Research studies in chronic cough

Chair(s): Andrea Portacci, Imran Satia

Session type: Poster session

Determination of Camlipixant (BLU-5937) P2X3 antagonist activity in a sensory neuronal model and bronchial epithelial cells

Orla Dunne

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Irritant stimuli evoke ATP and inflammatory mediator release affecting P2X3 responses.

Orla Dunne

Poster

Abstract

Change in objective cough count correlates with improvement in patient-reported outcomes of cough in patients with idiopathic pulmonary fibrosis

Jacky Smith

Poster

Abstract

Inhaled alkaline hypertonic divalent salts reduce refractory chronic cough frequency.

Hisham Waziri

Poster

Abstract

Prior and concomitant medication use in patients with refractory chronic cough: post-hoc analysis of SOOTHE

Jacky Smith

Poster

Abstract

Plasma and bronchoalveolar lavage ATP in refractory/unexplained chronic cough

James Wingfield Digby

Poster

Abstract

Refractory and unexplained chronic cough in adults treated in a cough centre.

Marta D?browska

Poster

Abstract

Atopy is it another treatable trait in management of patients with chronic cough?

Katarzyna Bia?ek-gosk

Poster

Abstract

Ozone-induced model of cough hypersensitivity for the selection of novel antitussive agents

Cataldo Martucci

Poster

Abstract

Effect of expiratory loadings on changes in oesophageal pH during coughing evoked by maximal lung emptying

Alessandra Sorano

Poster

Abstract

Frequency of cough triggers associated with worse quality of life in patients with chronic cough

Mustafaa Wahab

Poster

Abstract

Determinants for cough improvement with pulmonary rehabilitation

Ana Sofia Brites Grave

Poster

Abstract

Impact of type 2 biomarkers on changes in subjective cough outcomes in chronic cough

Mustafaa Wahab

Poster

Abstract

Patient perception on the effectiveness of guideline-based treatment for chronic cough

Mustafaa Wahab

Poster

Abstract

Effect of AX-8, a TRPM8 Agonist, on Cough Bouts in Refractory or Unexplained Chronic Cough Patients, a Proof-of-Concept Study

Jacky Smith

Poster

Abstract

Responder analysis of Leicester Cough Questionnaire domains from phase 3 trials of gefapixant (COUGH-1/COUGH-2)

Surinder S. Birring

Poster

Abstract

Critical role of sensory neuronal TRPA1 signals in mediating cough hypersensitivity in allergic rhinitis

Yu Fu

Poster

Abstract

Determination of Camlipixant (BLU-5937) P2X3 antagonist activity in a sensory neuronal model and bronchial epithelial cells

Orla Dunne

Poster

Abstract

Effect of a novel inhaled lidocaine powder formulation on cough threshold to nebulised distilled water in humans

Alessandra Sorano

Poster

Abstract

Development and validation of therapy outcome measures for inducible laryngeal obstruction and chronic cough.

Siobhan Ludlow

Poster

Abstract

CD39L1 levels in refractory/unexplained chronic cough patients, and relationship to cough counts

Michael A. Wortley

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}